See more : Thermaltake Technology Co., Ltd. (3540.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of Siemens Healthineers AG (SMMNY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Siemens Healthineers AG, a leading company in the Medical – Devices industry within the Healthcare sector.
- Cadeler A/S (CDLR) Income Statement Analysis – Financial Results
- B. Riley Financial, Inc. (RILY) Income Statement Analysis – Financial Results
- Babcock & Wilcox Enterprises, I (BWNB) Income Statement Analysis – Financial Results
- European Reliance General Insurance Company S.A. (ERPRF) Income Statement Analysis – Financial Results
- Man Wah Holdings Limited (1999.HK) Income Statement Analysis – Financial Results
Siemens Healthineers AG (SMMNY)
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 22.36B | 21.68B | 21.71B | 18.00B | 14.46B | 14.52B | 13.43B | 13.80B | 13.55B | 12.94B |
| Cost of Revenue | 13.90B | 13.97B | 13.58B | 11.05B | 8.88B | 8.72B | 7.96B | 8.03B | 8.08B | 7.87B |
| Gross Profit | 8.47B | 7.71B | 8.14B | 6.95B | 5.58B | 5.80B | 5.47B | 5.76B | 5.47B | 5.07B |
| Gross Profit Ratio | 37.87% | 35.56% | 37.47% | 38.63% | 38.59% | 39.92% | 40.72% | 41.77% | 40.36% | 39.19% |
| Research & Development | 1.92B | 1.87B | 1.79B | 1.55B | 1.34B | 1.33B | 1.28B | 1.25B | 1.15B | 1.06B |
| General & Administrative | 3.68B | 3.61B | 3.41B | 2.82B | 2.28B | 2.21B | 2.15B | 2.22B | 2.21B | 2.11B |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.68B | 3.61B | 3.41B | 2.82B | 2.28B | 2.21B | 2.15B | 2.22B | 2.21B | 2.11B |
| Other Expenses | 0.00 | 103.00M | 20.00M | 32.00M | 15.00M | -42.00M | 73.00M | -3.00M | -1.00M | -58.00M |
| Operating Expenses | 5.60B | 5.58B | 5.21B | 4.40B | 3.64B | 3.50B | 3.51B | 3.47B | 3.35B | 3.11B |
| Cost & Expenses | 19.49B | 19.55B | 18.79B | 15.44B | 12.52B | 12.22B | 11.47B | 11.51B | 11.43B | 10.97B |
| Interest Income | 119.00M | 85.00M | 48.00M | 33.00M | 53.00M | 38.00M | 41.00M | 12.00M | 14.00M | 19.00M |
| Interest Expense | 476.00M | 296.00M | 118.00M | 83.00M | 76.00M | 123.00M | 205.00M | 267.00M | 216.00M | 117.00M |
| Depreciation & Amortization | 1.22B | 1.56B | 1.34B | 1.04B | 815.00M | 620.00M | 530.00M | 572.00M | 591.00M | 563.00M |
| EBITDA | 4.22B | 3.78B | 4.26B | 3.52B | 2.84B | 2.93B | 2.53B | 2.81B | 2.72B | 2.55B |
| EBITDA Ratio | 18.88% | 17.44% | 19.62% | 19.53% | 19.44% | 20.22% | 18.87% | 20.90% | 20.12% | 19.76% |
| Operating Income | 2.87B | 2.22B | 2.92B | 2.48B | 2.00B | 2.32B | 1.96B | 2.29B | 2.12B | 1.96B |
| Operating Income Ratio | 12.83% | 10.26% | 13.44% | 13.76% | 13.80% | 15.95% | 14.60% | 16.60% | 15.63% | 15.17% |
| Total Other Income/Expenses | -344.00M | -205.00M | -124.00M | -59.00M | -41.00M | -103.00M | -162.00M | -246.00M | -199.00M | -87.00M |
| Income Before Tax | 2.53B | 1.93B | 2.80B | 2.40B | 1.95B | 2.19B | 1.80B | 2.04B | 1.92B | 1.88B |
| Income Before Tax Ratio | 11.29% | 8.89% | 12.89% | 13.36% | 13.51% | 15.11% | 13.40% | 14.82% | 14.16% | 14.50% |
| Income Tax Expense | 564.00M | 403.00M | 746.00M | 658.00M | 532.00M | 607.00M | 515.00M | 600.00M | 590.00M | 584.00M |
| Net Income | 1.94B | 1.51B | 2.04B | 1.73B | 1.41B | 1.57B | 1.27B | 1.43B | 1.31B | 1.28B |
| Net Income Ratio | 8.68% | 6.96% | 9.39% | 9.60% | 9.76% | 10.79% | 9.42% | 10.34% | 9.68% | 9.87% |
| EPS | 1.74 | 1.35 | 1.82 | 1.57 | 1.41 | 1.57 | 1.27 | 1.38 | 1.31 | 1.28 |
| EPS Diluted | 1.74 | 1.34 | 1.81 | 1.56 | 1.41 | 1.57 | 1.26 | 1.38 | 1.31 | 1.28 |
| Weighted Avg Shares Out | 1.12B | 1.12B | 1.12B | 1.10B | 1.00B | 999.25M | 999.90M | 1.00B | 1.00B | 1.00B |
| Weighted Avg Shares Out (Dil) | 1.12B | 1.12B | 1.13B | 1.10B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B |
Siemens Healthineers, GE Healthcare eye Medtronic units - Bloomberg News
Siemens Healthineers AG (SEMHF) CEO Bernd Montag on Q4 2022 Results - Earnings Call Transcript
Siemens Healthineers posts forecast-beating earnings and revenue, driven by imaging division
Siemens Healthineers: Looking Through The Short-Term Headwinds
Siemens Healthineers AG (SEMHF) CEO Bernhard Montag on Q3 2022 Results - Earnings Call Transcript
Siemens Healthineers Q3 earnings fall, confirms 2022 outlook
Siemens Healthineers: Solid, But No Buy Recommendation
Siemens Healthineers AG (SEMHF) CEO Bernd Montag on Q2 2022 Results - Earnings Call Transcript
Siemens Healthineers raises 2022 outlook on demand for COVID-19 tests
Siemens: A Very Sturdy German Industrial Stalwart
Source: https://incomestatements.info
Category: Stock Reports